vs

Side-by-side financial comparison of Heritage Global Inc. (HGBL) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

STANDARD BIOTOOLS INC. is the larger business by last-quarter revenue ($19.6M vs $11.9M, roughly 1.6× Heritage Global Inc.). Heritage Global Inc. runs the higher net margin — 2.5% vs -177.4%, a 179.9% gap on every dollar of revenue. On growth, Heritage Global Inc. posted the faster year-over-year revenue change (10.1% vs -11.5%). Heritage Global Inc. produced more free cash flow last quarter ($971.0K vs $-23.1M). Over the past eight quarters, Heritage Global Inc.'s revenue compounded faster (-1.3% CAGR vs -12.2%).

Global Media & Entertainment Limited, trading as Global, is a British media company formed in 2007. It is the owner of the largest commercial radio company in Europe having expanded through a number of historical acquisitions, including Chrysalis Radio, GCap Media, and GMG Radio. Global owns and operates seven core radio brands, all employing a national network strategy, including Capital, Heart, Smooth, Radio X, Gold, Classic FM, and LBC.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

HGBL vs LAB — Head-to-Head

Bigger by revenue
LAB
LAB
1.6× larger
LAB
$19.6M
$11.9M
HGBL
Growing faster (revenue YoY)
HGBL
HGBL
+21.6% gap
HGBL
10.1%
-11.5%
LAB
Higher net margin
HGBL
HGBL
179.9% more per $
HGBL
2.5%
-177.4%
LAB
More free cash flow
HGBL
HGBL
$24.1M more FCF
HGBL
$971.0K
$-23.1M
LAB
Faster 2-yr revenue CAGR
HGBL
HGBL
Annualised
HGBL
-1.3%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HGBL
HGBL
LAB
LAB
Revenue
$11.9M
$19.6M
Net Profit
$301.0K
$-34.7M
Gross Margin
48.5%
Operating Margin
6.5%
-168.5%
Net Margin
2.5%
-177.4%
Revenue YoY
10.1%
-11.5%
Net Profit YoY
248.3%
-28.8%
EPS (diluted)
$0.00
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HGBL
HGBL
LAB
LAB
Q4 25
$11.9M
Q3 25
$11.4M
$19.6M
Q2 25
$14.3M
$21.8M
Q1 25
$13.5M
$40.8M
Q4 24
$10.8M
Q3 24
$10.4M
$22.1M
Q2 24
$12.0M
$22.5M
Q1 24
$12.2M
$45.5M
Net Profit
HGBL
HGBL
LAB
LAB
Q4 25
$301.0K
Q3 25
$585.0K
$-34.7M
Q2 25
$1.6M
$-33.5M
Q1 25
$1.1M
$-26.0M
Q4 24
$-203.0K
Q3 24
$1.1M
$-26.9M
Q2 24
$2.5M
$-45.7M
Q1 24
$1.8M
$-32.2M
Gross Margin
HGBL
HGBL
LAB
LAB
Q4 25
Q3 25
-5.6%
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
HGBL
HGBL
LAB
LAB
Q4 25
6.5%
Q3 25
11.5%
-168.5%
Q2 25
15.6%
-118.1%
Q1 25
10.4%
-80.8%
Q4 24
13.8%
Q3 24
14.2%
-120.9%
Q2 24
29.5%
-134.5%
Q1 24
21.0%
-132.2%
Net Margin
HGBL
HGBL
LAB
LAB
Q4 25
2.5%
Q3 25
5.1%
-177.4%
Q2 25
11.4%
-153.7%
Q1 25
7.9%
-63.8%
Q4 24
-1.9%
Q3 24
10.5%
-122.0%
Q2 24
20.8%
-203.3%
Q1 24
14.8%
-70.6%
EPS (diluted)
HGBL
HGBL
LAB
LAB
Q4 25
$0.00
Q3 25
$0.02
$-0.09
Q2 25
$0.05
$-0.09
Q1 25
$0.03
$-0.07
Q4 24
$-0.01
Q3 24
$0.03
$-0.07
Q2 24
$0.07
$-0.12
Q1 24
$0.05
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HGBL
HGBL
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$20.5M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$67.0M
$399.7M
Total Assets
$88.4M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HGBL
HGBL
LAB
LAB
Q4 25
$20.5M
Q3 25
$19.4M
$129.4M
Q2 25
$19.8M
$158.6M
Q1 25
$18.8M
$150.9M
Q4 24
$21.7M
Q3 24
$26.6M
$210.6M
Q2 24
$24.6M
$269.8M
Q1 24
$15.6M
$287.1M
Total Debt
HGBL
HGBL
LAB
LAB
Q4 25
Q3 25
$4.1M
Q2 25
$4.2M
Q1 25
$4.4M
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
HGBL
HGBL
LAB
LAB
Q4 25
$67.0M
Q3 25
$66.5M
$399.7M
Q2 25
$65.7M
$424.5M
Q1 25
$65.4M
$454.6M
Q4 24
$65.2M
Q3 24
$66.1M
$489.3M
Q2 24
$65.8M
$510.3M
Q1 24
$63.0M
$577.3M
Total Assets
HGBL
HGBL
LAB
LAB
Q4 25
$88.4M
Q3 25
$86.5M
$539.6M
Q2 25
$87.7M
$557.0M
Q1 25
$86.7M
$579.6M
Q4 24
$81.3M
Q3 24
$88.5M
$681.5M
Q2 24
$90.0M
$708.7M
Q1 24
$83.7M
$777.7M
Debt / Equity
HGBL
HGBL
LAB
LAB
Q4 25
Q3 25
0.06×
Q2 25
0.06×
Q1 25
0.07×
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HGBL
HGBL
LAB
LAB
Operating Cash FlowLast quarter
$1.6M
$-22.2M
Free Cash FlowOCF − Capex
$971.0K
$-23.1M
FCF MarginFCF / Revenue
8.2%
-118.1%
Capex IntensityCapex / Revenue
5.1%
4.5%
Cash ConversionOCF / Net Profit
5.25×
TTM Free Cash FlowTrailing 4 quarters
$-2.3M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HGBL
HGBL
LAB
LAB
Q4 25
$1.6M
Q3 25
$61.0K
$-22.2M
Q2 25
$1.9M
$-20.7M
Q1 25
$2.6M
$-30.3M
Q4 24
$-5.5M
Q3 24
$5.5M
$-27.9M
Q2 24
$6.1M
$-39.0M
Q1 24
$1.7M
$-62.5M
Free Cash Flow
HGBL
HGBL
LAB
LAB
Q4 25
$971.0K
Q3 25
$-233.0K
$-23.1M
Q2 25
$1.7M
$-22.6M
Q1 25
$-4.8M
$-35.3M
Q4 24
$-5.5M
Q3 24
$5.5M
$-30.1M
Q2 24
$6.0M
$-41.0M
Q1 24
$1.7M
$-63.3M
FCF Margin
HGBL
HGBL
LAB
LAB
Q4 25
8.2%
Q3 25
-2.1%
-118.1%
Q2 25
12.0%
-103.6%
Q1 25
-35.6%
-86.6%
Q4 24
-51.2%
Q3 24
52.7%
-136.4%
Q2 24
49.7%
-182.2%
Q1 24
13.6%
-138.9%
Capex Intensity
HGBL
HGBL
LAB
LAB
Q4 25
5.1%
Q3 25
2.6%
4.5%
Q2 25
1.1%
8.7%
Q1 25
55.0%
12.4%
Q4 24
0.0%
Q3 24
0.3%
10.2%
Q2 24
0.6%
8.6%
Q1 24
0.2%
1.7%
Cash Conversion
HGBL
HGBL
LAB
LAB
Q4 25
5.25×
Q3 25
0.10×
Q2 25
1.15×
Q1 25
2.46×
Q4 24
Q3 24
5.07×
Q2 24
2.42×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HGBL
HGBL

Services$7.9M67%
Products$4.0M33%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons